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We examined the risk of lung cancer in relation to green tea consumption in a population-based cohort study in Japan among 41440
men and women, aged 40–79 years, who completed a questionnaire in 1994 regarding green tea consumption and other health-
related lifestyle factors. During the follow-up period of 7 years (from 1995 to 2001), 302 cases of lung cancer were identified, and the
Cox proportional hazards regression model was used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs). The
multivariable-adjusted HRs of lung cancer incidence for green tea consumption of 1 or 2, 3 or 4, and 5 or more cups/day as
compared to less than 1 cup/day were 1.14 (95% CI: 0.80–1.62), 1.18 (95% CI: 0.83–1.66), and 1.17 (95% CI: 0.85–1.61),
respectively (P for trend¼0.48). This cohort study has found no evidence that green tea consumption is associated with lung cancer.
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Lung cancer is the commonest cause of cancer death worldwide
(Parkin, 2001; Parkin et al, 2005) and now ranks first among
cancers in Japan. In 2005, lung cancer deaths accounted for
approximately 19% of all cancer deaths in Japan (23% in men and
13% in women, The Editorial Board of The Cancer Statistics in
Japan, 1952–2005).
Evidence from in vitro and animal experiments has suggested
that green tea polyphenols protect against lung cancer through
their antimutagenic and antioxidant properties (Valcic et al, 1996;
Okabe et al, 1997; Yang et al, 1998, 2005; Fujimoto et al, 2002;
Chen et al, 2004; Kuzuhara et al, 2007; Sadava et al, 2007). To the
best of our knowledge, only two studies (of atomic bomb survivors
and postmenopausal women) have investigated lung cancer risk in
relation to green tea or total tea consumption (Zheng et al, 1996;
Nagano et al, 2001), and both found no association.
In a population-based prospective study of men and women in
Miyagi Prefecture in northeastern Japan, where about 75% of the
population drinks green tea everyday (Suzuki et al, 2004), we
investigated further whether an association exists between green
tea consumption and lung cancer risk.
MATERIALS AND METHODS
The details of this Ohsaki National Health Insurance (NHI) cohort
study have been published elsewhere (Tsuji et al, 1998; Kikuchi
et al, 2006; Kuriyama et al, 2006; Nakaya et al, 2007). In brief,
a baseline self-administered questionnaire was distributed to all
NHI beneficiaries aged 40–79 years living in the catchment area
of the Ohsaki Public Health Center, Miyagi Prefecture, in
northeastern Japan from October to December 1994. From 54996
eligible individuals, 52029 (94.6%) individuals responded to the
survey. We considered the return of self-administered question-
naires signed by the participants to imply their consent to
participate in the study. The study protocol was approved by the
institutional review board of the Tohoku University Graduate
School of Medicine.
We excluded 776 individuals who had withdrawn from the NHI
before we started the prospective study, 3038 individuals with a
prior history of cancer, 6355 individuals with missing data on
green tea consumption, and 420 individuals who had reported
extreme daily energy intake (outside of the sex-specific cutoff
points of lower 0.5% and upper 0.5%). Finally, 41440 individuals
were involved in the final analysis.
The baseline survey questionnaire contained items on basic
personal health information and a food frequency questionnaire
(FFQ). Measurements of cigarette smoking included smoking
status (never, current, or past), number of cigarettes smoked per
day, and total years of cigarettes smoked. Five frequency categories
were used for the food consumption as almost never, 1–2 times/
month, 1–2 times/week, 3–4 times/week, and almost every day.
For green tea and coffee, the five categories were almost never,
occasionally, 1–2 cups/day, 3–4 cups/day, and more than 5 cups/
day. We combined the first two categories of green tea
consumption into a single category as less than 1 cup/day because
very few individuals selected those options. The validity of the FFQ
was assessed by calculating Spearman’s correlation coefficients
between four 3-day diet records collected during four seasons
within the year and the reproducibility evaluated by two FFQ 1
year apart. The results showed a reasonably high level of validity
and reproducibility. The corresponding Spearman’s correlation
coefficients between the diet records and FFQ on green tea for men
and women are 0.71 and 0.53, between the two FFQ are 0.63 for
men and 0.64 for women, respectively (Ogawa et al, 2003).
The end point in this study was lung cancer incidence defined as
code C34.0–C34.9, according to the International Classification of
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yDiseases for Oncology, second edition (ICD-O-2) (Percy et al,
1990). We ascertained the incidence of lung cancer through a
computerised record linkage to the Miyagi Prefecture Cancer
Registry, one of the oldest and most accurate population-based
cancer registries in Japan (Takano and Okuno, 1997). We followed
incidence of cancer, death, emigration, or loss of NHI qualification
of each study individual by obtaining their NHI claim history files
from the Miyagi NHI Association. The date and reasons of
withdrawal were obtained from the records of the NHI withdrawal
history files. Follow-up of the individuals who had withdrawn from
the NHI was discontinued because of logistic limitations.
Statistical analysis
We counted the person-years of follow-up for each individual from
1 January 1995 until the date of diagnosis of lung cancer, date of
Table 1 Baseline characteristics of individuals according to green tea consumption, the Ohsaki study
Green tea consumption, cups/day
o1 1 or 2 3 or 4 X5
Characteristics (n¼10950) (n¼8983) (n¼9024) (n¼12483)
Age in years, mean (s.d.) 58.0 (10.8) 58.7 (10.8) 60.7 (10.0) 61.9 (9.5)
Sex, no. (%)
Men 5959 (54.4) 4447 (49.5) 3998 (44.3) 5185 (41.5)
Women 4991 (45.6) 4536 (50.5) 5026 (55.7) 7298 (58.5)
Smoking status, no. (%)
Never 4634 (49.2) 4085 (53.4) 4459 (57.8) 5965 (56.7)
a
Former 1521 (16.1) 1116 (14.6) 1161 (15.0) 1551 (14.7)
Current, o20 cigarettes/day 1190 (12.6) 869 (11.4) 803 (10.4) 1226 (11.7)
Current, X20 cigarettes/day 2080 (22.1) 1578 (20.6) 1296 (16.8) 1786 (17.0)
Passive smoking, no. (%)
Yes 4190 (48.9) 3306 (49.0) 2942 (45.9) 4241 (49.5)
No 4378 (51.1) 3444 (51.0) 3467 (54.1) 4323 (50.5)
Alcohol drinking, no. (%)
Never 3910 (40.2) 3371 (42.6) 3749 (47.1) 5297 (48.7)
Former 838 (8.6) 576 (7.3) 560 (7.0) 844 (7.8)
Current, o45.6gday
 1 ethanol 2996 (30.8) 2506 (31.6) 2355 (29.6) 3151 (29.0)
Current, X45.6gday
 1 ethanol 1984 (20.4) 1470 (18.6) 1301 (16.3) 1592 (14.6)
Education level, no. (%)
Junior high school or lower 6306 (61.0) 4783 (55.8) 4855 (56.1) 7145 (59.7)
High school 3298 (31.9) 3055 (35.6) 3027 (35.0) 3841 (32.1)
College/university or higher 739 (7.1) 733 (8.6) 768 (8.9) 980 (8.2)
Walking duration, hday
 1, no. (%)
o1 5277 (52.9) 4507 (54.3) 4761 (57.2) 6377 (55.7)
X1 4706 (47.1) 3794 (45.7) 3556 (42.8) 5076 (44.3)
Body mass index, no. (%)
b
o18.5 348 (3.4) 255 (3.0) 259 (3.0) 368 (3.1)
18.5–24.9 6914 (67.7) 5807 (68.4) 5884 (68.7) 7918 (66.9)
X25 2950 (28.9) 2430 (28.6) 2421 (28.3) 3558 (30.0)
Marital status, no. (%)
Married 8027 (81.7) 6788 (82.8) 6831 (82.2) 9235 (80.6)
Widowed/divorced 1276 (13.0) 1063 (13.0) 1206 (14.5) 1899 (16.6)
Single 525 (5.3) 350 (4.3) 275 (3.3) 319 (2.8)
Family history of cancer, no. (%)
Yes 3139 (28.7) 2667 (29.7) 2949 (32.7) 4230 (33.9)
No 7811 (71.3) 6316 (70.3) 6075 (67.3) 8253 (66.1)
Total energy intake, mean (s.d.), kcalday
 1 1507 (594) 1516 (569) 1524 (544) 1554 (542)
Daily dietary consumption
Soybean products, mean (s.d.), g 44.7 (26.8) 48.5 (25.9) 50.9 (24.7) 53.5 (24.1)
Total meat, mean (s.d.), g 17.8 (16.0) 18.1 (15.2) 17.8 (14.2) 17.6 (14.9)
Total fish, mean (s.d.), g 53.7 (34.6) 56.1 (33.9) 59.2 (32.6) 63.4 (33.2)
Dairy products, mean (s.d.), g 130.0 (101.1) 139.9 (100.7) 145.7 (100.3) 147.1 (101.3)
Total fruits, mean (s.d.), g 78.9 (61.2) 90.6 (62.8) 101.0 (63.1) 111.6 (63.9)
Total vegetables, mean (s.d.), g 84.6 (54.7) 94.9 (55.6) 102.1 (54.8) 108.6 (57.1)
Coffee, X3 cups, no. (%) 1338 (13.5) 862 (11.3) 695 (9.2) 897 (8.8)
s.d.¼standard deviation.
aThe total percentage does not equal to 100 because of rounding, all the same.
bBody mass index was calculated as weight in kilograms divided by
height in metres squared.
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period (31 December 2001), whichever occurred first. We used the
Cox proportional hazards regression to estimate the hazard ratios
(HRs) and 95% confidence intervals (CIs) of lung cancer incidence
according to the categories of green tea consumption, using the
SAS software, version 9.1 (SAS Institute Inc., Cary, NC, USA). The
P-values for the test of linear trend were calculated by treating the
green tea consumption category as a continuous variable.
All reported P-values are two-side and the statistically significant
cut point is less than 0.05.
We considered the following variables as potential confounders
a priori: age at baseline (continuous variable), sex (men or
women), education level (junior high school or lower, high school
or higher), marital status (married, or widowed/divorced/single),
body mass index (calculated as weight in kilograms divided by
height in metres squared; o18.5, 18.5–24.9, or X25.0), time spent
walking (o1o rX1hday
 1), family history of cancer (yes or no),
smoking status (never, former, or current), number of cigarettes
smoked per day (continuous variable), years of smoking
(continuous variable), passive smoking (yes or no), alcohol
drinking (never, former, current ethanol drinking of
o45.6gday
 1, or current ethanol drinking of X45.6gday
 1),
daily total energy intake (continuous variable), daily consumption
of soybean products, total meat, total fish, dairy products, total
fruits, total vegetables (each food group was calculated by
combining the individual food item and treat as a continuous
variable), and consumption of coffee (never or occasionally, 1–2
cups/day, or X3 cups/day). The age and sex adjusted model, age,
sex, and smoking adjusted model were also computed and
compared with the multivariable-adjusted model. The interactions
between green tea consumption and confounders were tested
through the addition of cross-product terms to the multivariable-
adjusted model.
RESULTS
The baseline characteristics of the study individuals according to
green tea consumption are shown in Table 1. Women tended to
drink more green tea than men. The frequency of green tea
consumption increased with mean age at baseline. Individuals who
drank more green tea tended to consume more foods such as total
fish, total fruits, total vegetables, dairy products, soybean products,
as well as total energy. Green tea consumption was not related to
total meat consumption. Fewer daily coffee drinkers (X3 cups/
day) and alcohol drinkers were found in the high tea consumption
group. Other potential factors were unrelated to green tea
consumption, except for a moderate increase in the proportion
of individuals with family history of cancer.
During the 7-year follow-up (until 31 December 2001), 302 cases
of lung cancer were documented and 4928 individuals who
withdrew from the NHI were loss to follow-up. Table 2 shows
details of green tea consumption and lung cancer risk by the HRs
and 95% CIs. We found no association between green tea con-
sumption and lung cancer risk in women but a significant positive
association in men in the univariate model with no adjustment of
confounders, but this disappeared when age was taken into
account. The multivariable-adjusted HRs as compared to none or
less than 1 cup of green tea consumption per day were 1.14 (95%
CI: 0.80–1.62) for 1–2 cups/day, 1.18 (95% CI: 0.83–1.66) for
Table 2 Hazard ratios and 95% confidence intervals for lung cancer incidence according to green tea consumption category, the Ohsaki study
Green tea consumption, cups/day
o1 1 or 2 3 or 4 X5
Characteristics No. HR No. HR (95% CI) No. HR (95% CI) No. HR (95% CI) P for trend
a
All participants
Person-years of follow-up 66894 55390 56365 78627
No. of lung cancer 66 61 67 108
Crude 1.00 1.12 (0.79–1.58) 1.20 (0.86–1.69) 1.39 (1.02–1.89) 0.03
Age and sex-adjusted 1.00 1.14 (0.81–1.62) 1.16 (0.82–1.63) 1.28 (0.94–1.75) 0.12
Age, sex, smoke-adjusted 1.00 1.13 (0.80–1.60) 1.15 (0.82–1.62) 1.16 (0.85–1.59) 0.40
Multivariate adjusted
b 1.00 1.14 (0.80–1.62) 1.18 (0.83–1.66) 1.17 (0.85–1.61) 0.48
Men
Person-years of follow-up 36798 27516 24880 32653
No. of lung cancer 54 43 51 79
Crude 1.00 1.07 (0.71–1.59) 1.40 (0.95–2.05) 1.65 (1.17–2.33) o0.01
Age adjusted 1.00 1.04 (0.70–1.55) 1.17 (0.80–1.72) 1.27 (0.90–1.80) 0.41
Age and smoke-adjusted 1.00 1.01 (0.68–1.50) 1.16 (0.79–1.70) 1.12 (0.79–1.59) 0.43
Multivariate adjusted
b 1.00 1.05 (0.70–1.57) 1.21 (0.82–1.79) 1.17 (0.82–1.68) 0.32
Women
Person-years of follow-up 30096 27873
c 31485 45974
No. of lung cancer 12 18 16 29
Crude 1.00 1.62 (0.78–3.36) 1.27 (0.60–2.68) 1.57 (0.80–3.08) 0.31
Age adjusted 1.00 1.52 (0.73–3.15) 1.12 (0.53–2.37) 1.33 (0.68–2.61) 0.65
Age and smoke-adjusted 1.00 1.55 (0.75–3.22) 1.16 (0.55–2.45) 1.32 (0.67–2.58) 0.68
Multivariate adjusted
b 1.00 1.48 (0.71–3.10) 1.11 (0.52–2.37) 1.30 (0.65–2.60) 0.71
HR¼hazard ratio; CI¼confidence interval.
aThe P-values for the test of linear trend were calculated by treating the green tea consumption category as a continuous variable.
bThe multivariate HR has been adjusted for age (continuous variable), sex (men or women, among ‘all participants’), education level (junior high school or lower, high school, or
college/university or higher), marital status (married, or widowed/divorced/single), passive smoking (yes or no), body mass index (calculated as weight in kilograms divided by
height in metres squared; o18.5, 18.5–24.9, or X25.0), walking duration (o1o rX1hday
 1), family history of cancer (yes or no), smoking status (never, former, or currently),
number of cigarettes smoked per day (continuous variable), years of smoking (continuous variable), alcohol drinking (never, former, currently drinking o45.6gday
 1, or currently
drinking X45.6gday
 1 ethanol), total energy intake per day (continuous variable), and daily consumption of soybean products, total meat, total fish, dairy products, total fruits,
and total vegetables (for each food group, continuous variable), and consumption coffee (never or occasionally, 1–2 cups/day, or X3 cups/day).
cThe total person-years does
not equal to the sum of men and women because of rounding.
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day (P for trend¼0.48). The results were similar for men and
women. The comparison between the age and sex adjusted model,
the age, sex, and smoking adjusted model, and the different
multivariable-adjusted model suggested that the estimates were
stable. The findings did not change substantially after the lung
cancer cases diagnosed in the first 3 years of the follow-up were
excluded to avoid any bias of diet or lifestyle changes from
undiagnosed lung cancer present at baseline (data not shown).
When the data were stratified according to age, smoking status,
or other variables in the different categories, the results did not
change. Data in the subgroup did not show any significant
associations between lung cancer risk and green tea consumption
(Table 3). The multivariable-adjusted HRs for 1–2 cups/day, 3–4
cups/day, and 5 or more cups/day of green tea consumption when
compared with less than 1 cup/day were 1.07 (95% CI: 0.64–1.77),
1.41 (95% CI: 0.88–2.47), and 1.33 (95% CI: 0.85–2.07) respec-
tively, for current smokers (P for trend¼0.15). The corresponding
data for never smokers were 1.59 (95% CI: 0.68–3.69), 1.41 (95%
CI: 0.61–3.26), and 1.24 (95% CI: 0.54–2.84), respectively (P for
trend¼0.82). No significant interaction was observed in an
additional analysis for interactive effects between tea intake and
the corresponding confounders (data not shown).
DISCUSSION
In this large population-based prospective cohort study, we found
no association between green tea consumption and the risk of lung
cancer among this Japanese population, who consume green tea
much more frequently than people in Western countries. There
was no indication that green tea reduces lung cancer risk among
past smokers, current smokers, or passive smokers.
It has been hypothesised that the consumption of green tea may
decrease the risk of lung cancer risk, specifically in some
case–control studies (Ohno et al, 1995; Mendilaharsu et al, 1998;
Zhong et al, 2001; Hu et al, 2002). However, other case–control
studies found either no association (Le Marchand et al, 2000;
Bonner et al, 2005) or a positive association (Tewes et al, 1990).
The wide range and crude categorisation of tea consumption,
different study populations, choice of controls, inadequate control
for confounding, and inevitable recall bias might have obscured
Table 3 Stratified multivariate adjusted hazard ratios and 95% confidence intervals for lung cancer incidence according to green tea consumption
category, the Ohsaki Study
Green tea consumption, cups/day
o1 1 or 2 3 or 4 X5
Characteristics HR HR (95% CI) HR (95% CI) HR (95% CI) P for trend
a
Age
o60 1.00 0.80 (0.44–1.48) 1.09 (0.62–1.90) 1.11 (0.66–1.86) 0.52
X60 1.00 1.33 (0.85–2.06) 1.19 (0.77–1.86) 1.16 (0.77–1.74) 0.69
Smoking status
Never 1.00 1.59 (0.68–3.69) 1.41 (0.61–3.26) 1.24 (0.54–2.84) 0.82
Former 1.00 0.91 (0.42–1.97) 0.94 (0.45–1.97) 1.22 (0.63–2.36) 0.55
Current 1.00 1.07 (0.64–1.77) 1.41 (0.88–2.27) 1.33 (0.85–2.07) 0.15
Alcohol drinking
Never 1.00 1.38 (0.73–2.64) 1.10 (0.56–2.15) 1.18 (0.65–2.15) 0.82
Former 1.00 0.59 (0.15–2.35) 1.26 (0.41–3.84) 1.37 (0.52–3.60) 0.35
Current 1.00 1.11 (0.68–1.81) 1.34 (0.84–2.14) 1.23 (0.78–1.93) 0.31
Education level
Junior high school or lower 1.00 1.23 (0.81–1.86) 1.06 (0.69–1.62) 1.13 (0.77–1.67) 0.69
High school or higher 1.00 0.83 (0.41–1.69) 1.11 (0.57–2.15) 1.01 (0.54–1.90) 0.76
Walking duration, hday
 1
o1 1.00 0.96 (0.60–1.55) 0.90 (0.56–1.45) 0.84 (0.54–1.31) 0.42
X1 1.00 1.62 (0.92–2.86) 1.67 (0.95–2.93) 1.57 (0.93–2.65) 0.14
Body mass index
o25 1.00 1.04 (0.69–1.56) 1.06 (0.71–1.58) 1.10 (0.76–1.58) 0.62
X25 1.00 1.31 (0.62–2.79) 1.22 (0.56–2.66) 0.97 (0.46–2.04) 0.81
Family history of cancer
Yes 1.00 0.98 (0.52–1.85) 1.26 (0.70–2.28) 1.14 (0.66–1.97) 0.53
No 1.00 1.21 (0.79–1.84) 1.14 (0.74–1.75) 1.16 (0.78–1.72) 0.55
Coffee
o1 cup/day 1.00 1.00 (0.60–1.67) 1.23 (0.78–1.96) 1.10 (0.71–1.70) 0.55
X1 cups/day 1.00 0.89 (0.49–1.61) 0.95 (0.52–1.76) 1.11 (0.64–1.92) 0.63
HR¼hazard ratio; CI¼confidence interval. For each stratified variable the multivariate HR has been adjusted for age (continuous variable), sex (men or women), education level
(junior high school or lower, high school, or college/university or higher), marital status (married, or widowed/divorced/single), passive smoking (yes or no), body mass index
(calculated as weight in kilograms divided by height in metres squared; o18.5, 18.5–24.9, or X25.0), walking duration (o1o rX1hday
 1), family history of cancer (yes or no),
smoking status (never, former, or currently), number of cigarettes smoked per day (continuous variable), years of smoking (continuous variable), alcohol drinking (never, former,
currently drinking o45.6gday
 1, or currently drinking X45.6gday
 1 ethanol), total energy intake per day (continuous variable), and daily consumption of soybean products,
total meat, total fish, dairy products, total fruits, and total vegetables (for each food group, continuous variable), and consumption coffee (never or occasionally, 1–2 cups/day, or
X3 cups/day).
aThe P-values for the test of linear trend were calculated by treating the green tea consumption category as a continuous variable.
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those of the prospective cohort study of atomic bomb survivors in
Japan (Nagano et al, 2001) and postmenopausal women in
America (Zheng et al, 1996), although tea consumption was
differently categorised.
Our study had several strengths. Our individuals were recruited
from the general population. The information on green tea
consumption and other health-related lifestyle factors was
obtained before the individuals developed lung cancer, thus
avoiding recall bias. The questionnaire used had been tested and
a reasonably high level of validity and reproducibility was found.
Our sample size was appropriate given the high incidence in the
study region, and the period of follow-up was reasonably long.
Our study also had some limitations. First, the information on
green tea consumption and other lifestyle factors was collected
only once. Some individuals might have changed their frequency
of tea consumption during the follow-up so some misclassification
was inevitable. Second, we excluded 6355 individuals who had not
answered the question on green tea consumption and 420
individuals who had reported extreme daily energy intake, among
whom 52 lung cancers were diagnosed. The characteristics of
individuals without tea consumption details similar to those with
mean age (61.8 vs 59.9), percentage of men (51.3 vs 47.3), and
percentage of current smokers (29.4 vs 28.4). There was no
difference in lung cancer incidence between the individuals
included (n¼41440) and those excluded from the analysis
(n¼6775), and the HR was 1.03 (95% CI: 0.77–1.37; P¼0.85).
Thus, our results would not be substantially biased by exclusion of
the individuals without tea data. The third concern is the 11.9%
(4928 individuals) of participants lost to follow-up, but their
characteristics were similar to those who were fully followed-up
(n¼36512) with respect to: mean age (59.6 vs 58.0), percentage of
men (47.3 vs 39.6), % of current smokers (30.6 vs 28.9), and
percentage of individuals consuming more than 5 cups of green tea
per day (30.8 vs 26.1). Thus, our results would not be remarkably
biased by loss to follow-up.
This large population-based prospective cohort study in Japan
finds no evidence that the consumption of green tea reduces lung
cancer incidence.
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